Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-17-029618

Director sold 26,016 shares at $20.30 ($528,237)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2017-12-22 Sale −26,016 $20.30 $528,237 27,724 D: show line 1 in the form
Open-market sales · 26,016 sh · avg $20.30 · $528,237
Loading xslF345X03/doc4.xml…